Abstract

Background: Pharmacovigilance is an essential component of pharmacological sciences, encompassing the investigation, assessment, detection, and mitigation of adverse drug reactions with the aim of safeguarding pharmaceutical safety. Even while drugs have many advantages, patients who use many medications may experience unforeseen bad effects. Enhancing patient safety and optimizing the benefit-risk profile of medications across their whole lifespan depend on effective pharmacovigilance. Key players in national and international ADR monitoring include the Pharmacovigilance Programme of India (PvPI) and the Uppsala Monitoring Centre. Aim: To assess patients' awareness of and attitudes regarding reporting adverse drug reactions. Methods: A cross-sectional study was conducted among patients visiting for treatment at district hospital. Adult patients' knowledge, awareness, and reporting habits of ADRs were evaluated. Results: A response rate of 77.5% was recorded. Most were between the ages of 18 and 40. Just 8% knew what pharmacovigilance was and 38.7% knew what ADRs were. Notifying healthcare practitioners and halting medication were the main priorities for reporting ADRs. Common obstacles to reporting ADRs include ignorance and the belief that they are not significant. Conclusions: Despite their encounters with ADRs, the study reveals a gap in patients' knowledge and comprehension of ADR reporting. Keywords: Pharmacovigilance, Adverse Drug Reactions, ADR reporting, Patient safety.

Description